Exciting News: IBA Successfully Acquires Radcal Corporation

Today we are excited to announce the acquisition of Radcal Corporation by IBA. We look forward to a positive future that strengthens both companies market positions and expands resources for all.

Please join us in welcoming the IBA Team. We look forward to our continuing business and thank you for being a valued partner!

Highly complementary acquisition continues IBA’s expansion strategy to lead the Radiotherapy, Medical Imaging Dosimetry and Quality Assurance markets globally

Louvain-la-Neuve, Belgium, February 9, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, announced today it has signed an agreement to acquire all the assets of Radcal Corporation, a leader in diagnostic X-ray measurement based in California, USA. Through this acquisition, IBA will further strengthen its Medical Imaging Quality Assurance offering and its presence in the US market. Closing is expected on February 29, 2024. The acquisition is expected to be revenue accretive and EBIT positive from 2024.

Radcal is a pioneer in the X-ray imaging market, having introduced the first instrument providing comprehensive measures of X-ray dose with the ability to interchange sensors without loss in accuracy, almost 50 years ago. Today, Radcal’s systems remain a market leader, generating revenues of approximately USD 6 million in 2023 and employing 35 people.

The combination of Radcal into IBA’s business will support its continued growth in the dosimetry and quality assurance market, giving it an even greater foothold in the important US market and expanding its product offering beyond OEM and into the clinical setting. Further details of the acquisition were not disclosed.

Olivier Legrain, Chief Executive Officer at IBA, said: “This acquisition strengthens our position as a global leader in Medical Imaging Dosimetry and Quality Assurance, complementing our leading position in the radiotherapy market and diversifying our revenue sources. We see tremendous potential for the combined business both in the US and the international market and look forward to working closely with the Radcal team to continue the strong growth of its leading offering.”

Jean-Marc Bothy, President of IBA Dosimetry, added: “We are delighted to welcome the talented and dedicated Radcal team to IBA group. We are committed to providing the very best in medical imaging and radiotherapy quality assurance to our customers globally, contributing to our ultimate goal to treat more patients safely. Radcal’s growing product offering will enable us to reach new customers in the US and expand our presence in the Medical Imaging Quality Assurance market internationally.”

***ENDS**

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,000 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at: www.iba-worldwide.com

 

 

NEW AND DEVELOPED FOR YOU!

Radcal is excited to introduce our new 10X6-60DAP chamber for measuring DAP and DAP Rate on CBCT systems. This time saving chamber can be combined with any of our Accu-Gold+ or Touch System platforms and is an easy addition to our already comprehensive array of measurement capabilities.

The Chamber can display data in Gy-m2 and Gy-cm2.

If you have a Radcal meter or need a new meter with DAP measurement capability designed to measure on challenging CBCT systems please contact Sales@Radcal.com, 626-357-7921 ext 111.

Radcal is proud to offer the Accu-Gold Touch family of X-ray test systems

As a premier provider of diagnostic radiation test instruments, Radcal is excited to offer our stand-alone instruments, the Accu-Gold Touch Series. These measurement systems incorporate the largest customizable capacitive 5-inch touchscreen in the industry for a bright and straightforward user experience. In addition, the Accu-Gold Touch provides access to the full lineup of Accu-Gold sensors, the most extensive line of x-ray quality assurance sensors available. The Accu-Gold Touch provides the accuracy and reliability you’ve come to expect from Radcal in an economical package.

Alternatively, The Accu-Gold Touch Professional Series provides wired and wireless computer interfaces. Using the Accu-Gold Windows application users are able to access a rich set of advanced capabilities such as automated Excel-based reporting and waveform analysis. Current Accu-Gold system users should explore our Accu-Gold Touch conversion option.

Fluoro DAP (KAP) QA is Easy with the PDC

JCAHO (The Joint Commission: Accreditation, Health Care, Certification) has recently released new requirements regarding accuracy of Dose Area Product (DAP) or (KAP) meters as applied to Fluoroscopy applications. Excellent discussions of this emerging requirement can be found at:

https://www.aapm.org/pubs/reports/detail.asp?docid=161

While this is a new requirement, Radcal has provided a solution to independently measure DAP and KAP for over 10 years. This solution is the Radcal PDC (Patient Dose Calibrator). The PDC is simple to use, displaying DAP (KAP) and dose rate during an exposure then automatically switching to display accumulated DAP (KAP) and dose on exposure completion. The PDC is an ideal instrument for satisfying the new JCAHO requirements. For a full description go to DAPcheck (PDC).

Get in TOUCH with Radcal!

Accu-Gold+ Touch

Press Release

Radcal Corporation, Monrovia, California, announces today their new stand-alone diagnostic x-ray instrument as part of the Accu-Gold Family of meters.

Monrovia, CA, November 20, 2017: Radcal Corporation announces today that they will demonstrate at the RSNA 2017 a new line of stand-alone Accu-Gold instruments. With the largest 5 inch touchscreen in the industry these systems make diagnostic x-ray quality assurance even faster and easier.

Radcal officially releases the Accu-Gold Touch family of systems

As a premier provider of diagnostic radiation test instruments, Radcal is excited to announce the release of a new line of stand-alone instruments, the Accu-Gold Touch Series. These measurement systems incorporate the largest capacitive 5 inch touchscreen in the industry for a bright and straightforward user experience. In addition, the Accu-Gold Touch provides access to the full lineup of Accu-Gold sensors, the most extensive line of x-ray quality assurance sensors available. The Accu-Gold Touch provides the accuracy and reliability you’ve come to expect from Radcal in an economical package.

Alternatively, The Accu-Gold Touch Professional Series provides wired and wireless computer interfaces. Using the Accu-Gold Windows application users are able to access a rich set of advanced capabilities such as automated Excel-based reporting and waveform analysis. Current Accu-Gold system users should explore our Accu-Gold Touch conversion option.

Radcal will be demonstrating these instruments at RSNA 2017. Visit our booth #1529 for more information.